Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors — Stella

Recruiting

Back to Solid Tumor, Adult trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Australia

Melbourne Theranostic Innovation Centre (MTIC), North Melbourne, Victoria

Key details

Phase

Early testing

Sponsor

Monopar Therapeutics

Enrollment target

~12 participants

Started

October 2024

Primary completion

December 2026

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov